Clinical and Ecological Impact of a Primary Care Antimicrobial Stewardship Program Based on Telematic Educational Interviews (TELÉMACO Trial)
Launched by FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SEVILLA · Nov 22, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The TELÉMACO Trial is studying how a special program aimed at improving the use of antibiotics can help patients with community-acquired infections, which are infections that people get outside of hospitals. This trial involves primary care centers, and it uses telematic educational interviews, meaning that healthcare professionals will have virtual meetings to discuss best practices for prescribing antibiotics. The goal is to see if this approach can lead to better patient outcomes and reduce the negative effects of antibiotics on our health and the environment.
If you are a patient receiving care at a primary care center linked to the University Hospital Virgen del Rocío, you may be eligible to participate in this trial. The trial is currently recruiting participants of all ages and genders, but it does not include those who are being treated in emergency departments or dental offices. If you join, you can expect to take part in discussions about antibiotics and learn how to use them responsibly, which can ultimately help you and your community stay healthier.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • a) Primary Care centres within the reference area of the University Hospital Virgen del Rocío.
- Exclusion criteria:
- • 1. Emergency departments.
- • 2. Odontology offices.
- • 3. DDD per Health centre less than 5.78
About Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
The Fundación Pública Andaluza para la Gestión de la Investigación en Sevilla is a public foundation dedicated to advancing clinical research and innovation within the Andalusian healthcare system. By fostering collaboration among healthcare professionals, researchers, and institutions, the foundation aims to enhance the quality and efficiency of clinical trials. With a strong focus on ethical standards and regulatory compliance, it plays a pivotal role in supporting the development of new therapies and improving patient outcomes in the region. Through its commitment to scientific excellence and community health, the foundation contributes significantly to the advancement of medical knowledge and practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sevilla, , Spain
Patients applied
Trial Officials
José Miguel Cisneros Herreros, MD-PhD
Study Director
Hospitales Universitarios Virgen del Rocío
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported